Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
+22.5M
-
Total reported value, excl. options
-
$4.57B
-
Value change
-
+$938M
-
Put/Call ratio
-
1.15
-
Number of buys
-
127
-
Number of sells
-
-65
-
Price
-
$40.85
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2024
214 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q2 2024.
Avidity Biosciences, Inc. - Common Stock (RNA) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 120M outstanding shares and own 93.17% of the company stock.
Largest 10 shareholders include FMR LLC (16.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.9M shares), RTW INVESTMENTS, LP (8.81M shares), BlackRock Inc. (8.62M shares), Avoro Capital Advisors LLC (6.51M shares), VANGUARD GROUP INC (5.94M shares), RA CAPITAL MANAGEMENT, L.P. (5.4M shares), COWEN AND COMPANY, LLC (5.13M shares), WELLINGTON MANAGEMENT GROUP LLP (3.8M shares), and JANUS HENDERSON GROUP PLC (3.66M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.